Development of experimental model of chronic pyelonephritis with Escherichia coli O75:K5:H-bearing Dr fimbriae. Mutation in the dra region prevented tubulointerstitial nephritis

Journal of Clinical Investigation

Volumn 99, Issue 7, 1997, Pages 1662-1672

  Goluszko, Pawel ^a   Moseley, Steve L ^b   Truong, Luan D ^c   Kaul, Anil ^a   Williford, John R ^b   Selvarangan, Rangaraj ^a   Nowicki, Stella ^a   Nowicki, Bogdan ^a,d  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

attachment; collagen type IV; decay accelerating factor; Dr fimbriae; Escherichia coli

Indexed keywords

COLLAGEN TYPE 4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL VIRULENCE; BASEMENT MEMBRANE; CELL ADHESION; CHRONIC PYELONEPHRITIS; CONTROLLED STUDY; DRUG RECEPTOR BINDING; ESCHERICHIA COLI; EXPERIMENTAL MODEL; IMMUNE RESPONSE; KIDNEY HOMOGENATE; MOUSE; NONHUMAN; PRIORITY JOURNAL; URINARY TRACT INFECTION;

EID: 0030892286     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119329     Document Type: Article

References (48)

1. Warren, J.W. 1996. Clinical presentation and epidemiology of urinary tract infections. In Urinary Tract Infections. H.L.T. Mobley and J.W. Warren, editors. ASM Press, Washington, DC. 3-27.
2. Nowicki, B.J. 1996. In vitro models for the study of uropathogens. In Urinary Tract Infections. H.L.T. Mobley and J.W. Warren, editors. ASM Press, Washington, DC. 341-376.
3. Nowicki, B.J., L. Truong, J. Moulds, and R. Hull. 1988. Presence of the Dr receptor in normal human tissues and its possible role in the pathogenesis of ascending urinary tract infection. Am. J. Pathol. 133:1-4.
4. Jann, K., B. Jann, and G. Schmidt. 1981. SDS polyacrylamide gel electrophoresis and serological analysis of pili from Escherichia coli of different pathogenic origin. FEMS (Fed. Eur. Microbiol. Soc.) Microbiol. Lett. 11:21-25.
5. Korhonen, T., R. Virkola, V. Väisäsen-Rhen, and H. Holthöfer. 1986. Binding of purified Escherichia coli O75X adhesin to frozen sections of human kidney. FEMS (Fed. Eur. Microbiol. Soc.) Microbiol. Lett. 35:313-318.
6. Korhonen, T.K. 1979. Yeast cell agglutination by purified enterobacterial pili. FEMS (Fed. Eur. Microbiol. Soc.) Microbiol. Lett. 6:421-425.
7. Korhonen, T.K., R. Virkola, and H. Holthöfer. 1986. Localization of binding sites for purified Escherichia coli P fimbriae in the human kidney. Infect. Immun. 54:328-332.
8. Mobley, H.L.T., G.R. Chippendale, J.H. Tenney, R.A. Hull, and J.W. Warren. 1987. Expression ol Type 1 fimbriae may be required for persistence of Escherichia coli in the catheterized urinary tract. J. Clin. Microbiol. 25:2253-2257.
9. Marre, R., B. Kreft, and J. Hacker. 1990. Genetically engineered S and F1C fimbriae differ in their contribution to adherence of Escherichia coli to cultured renal tubular cells. Infect. Immun. 58:3434-3437.
10. k antigen as receptor for the haemagglutinin of pyelonephritic Escherichia coli. FEMS (Fed. Eur. Microbiol. Soc.) Microbiol. Lett. 7:297-302.
11. Karr, J.F., B.J. Nowicki, L.D. Truong, R.A. Hull, and S.I. Hull. 1989. Purified P fimbriae from two cloned gene clusters of a single pyelonephritogenic strain adhere to unique structures in the human kidney. Infect. Immun. 57: 3594-3600.
12. Leffler, H., and C. Svanborg-Edén. 1980. Chemical identification of a glycosphingolipid receptor for Escherichia coli attaching to human urinary tract epithelial cells and agglutinating human erythrocytes. FEMS (Fed. Eur. Microbiol. Soc.) Microbiol. Lett. 8:127-134.
13. Nowicki, B.J., H. Holthöfer, T. Saraneva, M. Rhen, V. Väisäsen-Rhen, and T.K. Korhonen. 1986. Location of adhesion sites for P-fimbriated and for O75X-positive Escherichia coli in the human kidney. Microb. Pathog. 1:169-180.
14. Westerlund, B., P. Kuusela, J. Risteli, T. Vartio, H. Rauvala, R. Virkola, and T.K. Korhonen. 1989. The O75X adhesin of uropathogenic Escherichia coli is a type IV collagen-binding protein. Mol. Microbiol. 3:329-337.
15. Nowicki, B.J., A. Hart, K.E. Coyne, D.M. Lublin, and S. Nowicki. 1993. Short consensus repeat-3 domain of recombinant decay-accelerating factor is recognized by Escherichia coli recombinant Dr Adhesin in a model of a cell-cell interaction. J. Exp. Med. 178:2115-2121.
16. Nowicki, B.J., J. Barrish, T. Korhonen, R.A. Hull, and S.I. Hull. 1987. Molecular cloning of the Escherichia coli O75X Adhesin. Infect. Immun. 55: 3168-3173.
17. Heptinstall, R.H. 1983. Pyelonephritis: pathologic features. In Pathology of the Kidney. R. Heptinstall, editor. 3rd ed. Little, Brown and Company, Boston. 1323-1396.
18. Risdon, R. Anthony. 1994. Pyelonephritis and reflux nephropathy. In Renal Pathology with Clinical and Functional Correlations. C.C. Tisher and B.M. Brenner, editors. 2nd ed. J.B. Lippincott Co., Philadelphia. 842-852.
19. Hagberg, L., I. Enherg, R. Freter, J. Lam, S. Olling, and C. Svanborg-Edén. 1983. Ascending, unobstructed urinary tract infection in mice caused by pylonephritogenic Escherichia coli of human origin. Infect. Immun. 40:273-283.
20. Nowicki, B.J., J. Moulds, R.A. Hull, and S.I. Hull. 1988. A hemagglutinin of uropathogenic Escherichia coli recognizes the Dr blood group antigen. Infect. Immun. 56:1057-1060.
21. Simon, R., U. Priefer, and A. Pühler. 1983. A broad host range mobilization system for in vivo genetic engineering: transposon mutagenesis in Gram negative bacteria. Biotechnology. 1:784-791.
22. Miller, V.L., and J.J. Mekalanos. 1988. A novel suicide vector and its use in construction of insertion mutations: osmoregulation of outer membrane proteins and virulence determinants in Vibrio cholerae requires tox R. J. Bacteriol. 170:2575-2583.
23. Bilge, S.S., C.R. Clausen, W. Lau, and S.L. Moseley. 1989. Molecular characterization of a fimbrial adhesin. F1845, mediating diffuse adherence of diarrhea-associated Escherichia coli to HEp-2 cells. J. Bacteriol. 171:4281-4289.
24. Manoil, C. 1990. Analysis of protein localization by use of gene fusions with complementary properties. J. Bacteriol. 172:1035-1042.
25. Carnoy, C.C., and S.L. Moseley. 1997. Mutational analysis of receptor-binding mediated by the Dr family of Escherichia coli adhesins. Mol. Microbiol. In press.
26. Nowicki, B.J., C. Svanborg-Eden, R.A. Hull, and S.I. Hull. 1989. Molecular analysis and epidemiology of the Dr hemagglutinin of uropathogenic Escherichia coli. Infect. Immun. 57:446-451.
27. Bilge, S.S., J.A. Apostol, K.J. Fuller, and S.L. Moseley. 1993. Transcriptional organization of the F1845 fimbrial adhesin determinant of Escherichia coli. Mol. Microbiol. 7:993-1006.
28. Roberts, J.A., M.B. Kaack, G. Baskin, and S.B. Svenson. 1993. Prevention of renal scarring from pyelonephritis in nonhuman primates by vaccination with a synthetic Escherichia coli serotype 08 oligosaccharide-protein conjugate. Infect. Immun. 61:5214-5218.
29. Goetz, M.B., and F.J. Silverblatt. 1987. Stimulation of human polymorphonuclear leukocyte oxidative metabolism by type 1 pili from Escherichia coli. Infect. Immun. 55:534-540.
30. Mangan, D.F., and I.S. Snyder. 1979. Mannose-sensitive interaction of Escherichia coli with human peripheral leukocytes in vitro. Infect. Immun. 26: 520-527.
31. Mundi H., B. Björkstén, C. Svanborg, L. Öhman, and C. Dahlgren. 1991. Extracellular release of reactive oxygen species from human neutrophils upon interaction with Escherichia coli strains causing renal scarring. Infect. Immun. 59:4168-4172.
32. Gupta, R., N.K. Ganguly, V. Ahuja, K. Joshi, and S. Sharma. 1995. An ascending nonobstructive model for chronic pyelonephritis in BALB/c mice. J. Med. Microbiol. 43:33-36.
33. Mobley, H.L.T., K.G. Jarvis, J.P. Elwood, D.I. Whittle, C.V. Lockatell, R.G. Russell, D.E. Johnson, M.S. Donnenberg, and J.W. Warren. 1993. Isogenic P-fimbrial deletion mutants of pyelonephritogenic Escherichia coli: the role of αGal(1-4) βGal binding in virulence of a wild-type strain. Molec. Microbiol. 10:143-155.
34. Johnson, J.R., K.M. Skubitz, B.J. Nowicki, K. Jacques-Palaz, and R.M. Rakita. 1995. Nonlethal adherence to human neutrophils mediated by Dr antigen specific adhesins of Escherichia coli. Infect. Immun. 3:309-316.
35. Bhathena, D.B., J.H. Weiss, N.H. Holland, R.G. McMorrow, J.J. Curtis, B.A. Lucas, and R.G. Luke. 1980. Focal and segmental glomerular sclerosis in reflux nephropathy. Am. J. Med. 68:886-892.
36. Rennke, H.G. 1984. Hemodynamically mediated glomerula damage following reduction of functioning nephron units. In Pyelonephritis: Urinary Tract Infection. H. Losse, A.W. Asschen, A.E. Lisor, and V.T. Andriole, editors. George Thieme, Verlag, Stuttgart, Germany. 66-68.
37. Bhagavan, B.S., R.E. Wenk, and D. Dutta. 1979. Pathways of urinary hackflow in obstructive uropathy. Demonstration by pigmented gelatin injection and Tamm-Horsfall uromucoprotein markers. Hum. Pathol. 10:669-683.
38. Miettinen, A.B., A.M. Westerlund, T. Tarkkanen, P. Törnroth, P. Ljungberg, O.V. Renkonen, and T.K. Korhonen. 1993. Binding of bacterial adhesin to rat glomerular mesangium in vivo. Kidney Int. 43:592-600.
39. Arthur, M., C.E. Johnson, R.H. Rubin, R.D. Arbeit, C. Campanelli, C. Kim, S. Steinbach, M. Agarwal, R. Wilkinson, and R. Goldstein. 1989. Molecular epidemiology of adhesin and hemolysin virulence factors among uropathogenic Escherichia coli. Infect. Immun. 57:303-313.
40. Pham, T., A. Kaul, A. Hart, P. Goluszko, J. Moulds, S. Nowicki, D. Lublin, and B.J. Nowicki. 1995. dra-Related X adhesins of gestational pyelonephritis-associated Escherichia coli recognize SCR-3 and SCR-4 domains of recom-binant decay accelerating factor. Infect. Immun. 63:1663-1668.
41. Giron, J.A., T. Jones, F. Millan-Villasco, E. Castro-Munoz, L. Zarate, J. Fry, G. Frankel, S.L. Moseley, B. Baudrey, and J.B. Kaper. 1991. Diffuse-adhering Escherichia coli (DAEC) as a putative cause of diarrhea in Mayan children in Mexico. J. Infect. Dis. 163:507-513.
42. 2 in basement membranes and mesangium of the kidney. J. Cell Biol. 85:597-616.
43. Ichida, S., Y. Yuzawa, H. Okada, K. Yoshioka, and S. Matsuo. 1994. Localization of the complement regulatory proteins in the normal human kidney. Kidney Int. 46:89-96.
44. Nowicki, B.J., M.G. Martens, A. Hart, and S. Nowicki. 1994. Gestational age-dependent distribution of Escherichia coli fimbriae in pregnant patients with pyelonephritis. Ann. NY Acad. Sci. 730:290-291.
45. Crabtree, E.F., G.C. Prather, and E.L. Prien. 1940. End results of urinary tract infections associated with pregnancy. Am. J. Obstet. Gynecol. 40:17.
46. Weiss, S., and F. Parker. 1939. Pyelonephritis: its relation to vascular lesions and arterial hypertension. Medicine. 18:221.
47. Advisory Committee to the Renal Transplant Registry. 1975. Twelfth report of the human renal transplant registry. JAMA (J. Am. Med. Assoc.). 233: 787.
48. Heptinstall, R.H. 1983. Pyelonephritis: pathologic features. In Pathology of the Kidney. R. Heptinstall, editor. 3rd ed. Little, Brown and Company. Boston. 1323 pp.